[ad_1]
From the AIDS Foundation case And the HIV / AIDS network in Thailand filed an objection to the patent application for anti-HIV drug. And the treatment of the hepatitis C virus in the Department of Intellectual Property since 2015. But the Department did not consider it.
Nimit Tienyudom, director of the AIDS Foundation, said the foundation had filed objections to the anti-HIV patent application. And the treatment of hepatitis C from the year 2558 until the completion of the process, but the department has not completed. And we do not know when to finish. Which has a great effect. Do not rush to check or point in any way. Patent applicants may claim that this drug is patented from the filing date of the application if the Department determines that it has no rights. Other pharmaceutical companies will also start producing drugs. Cause competition And drug prices will go down. Health insurance can negotiate more. If no monopoly By spending the same amount of money. This will increase the number of tablets. More patients have access to the drug.
"Intellectual property must not be a monopoly tool, it is not accessible to people, both are needed." 5 patent applications filed by the foundation We know that the five applications are not eligible to a patent, such as a new drug, or take the old medicine in a new tablet until the patients do not reach the drug Antiretroviral therapy And hepatitis C medications. The patent is expensive and has an impact on people's lives, "said the director of the AIDS Access Foundation.
Mr. Nimit further provided information. DDS database This is not effective Can not know what are the details of the patent. When you send a letter to the department. I have not filed a patent application yet. Some pharmaceutical companies ask for this period when the foundation asks whether this is contemplated or not, when the ministry has had a major impact on people's lives. Because it's a monopoly in sales production only. And then guaranteed by the Department of Intellectual Property.
The foundation and the infection network. Request the Intellectual Property Department to: 1. Clarify the delay 2. Give the public assurance that the information submitted after publication is intended for the examination of the patent application. Will be considered with other sources. 3. Show responsibility for providing false information. Especially for TAF and 4. The database system must be modified immediately to allow easy searching. Complete, accurate and timely information.
[ad_2]
Source link
